Priya Singhal - 30 Jun 2023 Form 4 Insider Report for BIOGEN INC. (BIIB)

Signature
/s/ Wendell Taylor, attorney-in-fact for Priya Singhal
Issuer symbol
BIIB
Transactions as of
30 Jun 2023
Net transactions value
-$66,495
Form type
4
Filing time
05 Jul 2023, 17:33:37 UTC
Previous filing
06 Apr 2023
Next filing
06 Sep 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIIB Common Stock Options Exercise $0 +315 +11% $0.000000 3,158 30 Jun 2023 Direct
transaction BIIB Common Stock Tax liability $43,582 -153 -4.8% $284.85 3,005 30 Jun 2023 Direct
transaction BIIB Common Stock Sale $22,912 -81 -2.7% $282.87 2,924 03 Jul 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Restricted Stock Unit Options Exercise $0 -315 -100% $0.000000* 0 30 Jun 2023 Common Stock 315 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This award was granted to the reporting person on July 1, 2020 and vested in three equal installments on each anniversary of the grant date.